ES2187897T3 - Composicion anticancer. - Google Patents

Composicion anticancer.

Info

Publication number
ES2187897T3
ES2187897T3 ES98307766T ES98307766T ES2187897T3 ES 2187897 T3 ES2187897 T3 ES 2187897T3 ES 98307766 T ES98307766 T ES 98307766T ES 98307766 T ES98307766 T ES 98307766T ES 2187897 T3 ES2187897 T3 ES 2187897T3
Authority
ES
Spain
Prior art keywords
powder
bambu
anticancer composition
preferently
ramified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98307766T
Other languages
English (en)
Inventor
Shigetomi Kumon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Corp
Asahi Tsusho Co Ltd
Original Assignee
Asahi Corp
Asahi Tsusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Corp, Asahi Tsusho Co Ltd filed Critical Asahi Corp
Application granted granted Critical
Publication of ES2187897T3 publication Critical patent/ES2187897T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

EL BAMBU EN POLVO SE USA COMO INGREDIENTE ACTIVO EN COMPOSICIONES PARA REDUCIR LA INCIDENCIA DE CANCER DE COLON Y RECTO. EL POLVO DE BAMBU SE OBTIENE PREFERENTEMENTE DE LAS PARTES INFERIORES NO RAMIFICADAS DEL TALLO DE PLANTAS DE TRES O MAS AÑOS, O DE BAMBU CORTADO DURANTE LOS TRES MESES PREVIOS A LA APARICION DE LOS BROTES. JUNTO CON EL POLVO DE BAMBU SE PUEDEN MEZCLAR POLVO DE SEMILLA DE CALABAZA, POLVO DE AJO, QUESO EN POLVO, HARINA DE TRIGO Y AGUA, DEJANDOSE QUE LA MEZCLA SE MACERE, OBTENIENDOSE ASI UN PRODUCTO ESPECIALMENTE BENEFICIOSO.
ES98307766T 1997-11-12 1998-09-24 Composicion anticancer. Expired - Lifetime ES2187897T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32698197A JP3497362B2 (ja) 1997-11-12 1997-11-12 発癌抑制薬

Publications (1)

Publication Number Publication Date
ES2187897T3 true ES2187897T3 (es) 2003-06-16

Family

ID=18193974

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98307766T Expired - Lifetime ES2187897T3 (es) 1997-11-12 1998-09-24 Composicion anticancer.

Country Status (9)

Country Link
US (1) US6391307B1 (es)
EP (1) EP0919240B1 (es)
JP (1) JP3497362B2 (es)
KR (1) KR100301784B1 (es)
CN (1) CN1092977C (es)
AU (1) AU728928B2 (es)
CA (1) CA2249418C (es)
DE (1) DE69809375T2 (es)
ES (1) ES2187897T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002217832A1 (en) * 2000-11-15 2002-05-27 Rutgers, The State University Of New Jersey Black tea extract for prevention of disease
KR100670840B1 (ko) * 2004-08-20 2007-01-18 담양군 탁산계 약물의 효능 증가제로서의 죽초액의 용도
ITBA20080008A1 (it) * 2008-02-22 2009-08-23 Michele Barone Composizioni comprendenti fitoestrogeni selettivi per il recettore estrogenico beta e fibre dietetiche
US8125049B2 (en) * 2009-11-16 2012-02-28 International Business Machines Corporation MIM capacitor structure in FEOL and related method
US20110142993A1 (en) * 2009-12-10 2011-06-16 Timothy Bowser Method for Making Pet and Animal Comestibles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62148425A (ja) 1985-12-20 1987-07-02 Mitsutoyo:Kk 笹の葉および稈から薬効物質を製造する方法
HU196559B (en) * 1987-04-17 1988-12-28 Biogal Gyogyszergyar Process for production of capsules of big stability from mild gelatine for medical purpuses containing as active substance of oils of natural origin
NO882653D0 (no) * 1988-06-15 1988-06-15 Apothekernes Lab Doseringsform.
CH675685A5 (es) * 1988-06-24 1990-10-31 Flachsmann Ag Emil
ES2086631T3 (es) * 1991-12-23 1996-07-01 Nat Starch Chem Invest Fibra dietetica derivada de tapioca.

Also Published As

Publication number Publication date
US6391307B1 (en) 2002-05-21
DE69809375D1 (de) 2002-12-19
JPH11139982A (ja) 1999-05-25
EP0919240A1 (en) 1999-06-02
KR19990044830A (ko) 1999-06-25
JP3497362B2 (ja) 2004-02-16
EP0919240B1 (en) 2002-11-13
DE69809375T2 (de) 2003-08-21
CN1092977C (zh) 2002-10-23
AU728928B2 (en) 2001-01-18
KR100301784B1 (ko) 2001-09-06
AU8702198A (en) 1999-08-26
CN1217209A (zh) 1999-05-26
CA2249418C (en) 2002-07-16
CA2249418A1 (en) 1999-05-12

Similar Documents

Publication Publication Date Title
ES8106654A1 (es) Procedimiento para la fabricacion de compuestos para el tra-tamiento del cancer
MXPA02011235A (es) Preparacion de liposomas.
MX9308012A (es) Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
MXPA04003487A (es) Queratinocitos utilizables como sustancia biologicamente activa en el tratamiento de heridas.
HRP20110050T1 (hr) Kristalni oblici (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenol hidroklorida za upotrebu u farmaceutskim sastavima kao aktivnog sastojka
ES2067548T3 (es) Composiciones de enmascaramiento del sabor desagradable y procedimientos para su preparacion.
HN1999000080A (es) Derivados de isotiazol utiles como agentes anticancerosos.
ES2046083B1 (es) Procedimiento para preparar composiciones de liberacion prolongada.
HN2001000273A (es) Metodos y composiciones para la proteccion de plantas y cultivos.
UY28271A1 (es) Compuestos químicos
MY177027A (en) Novel dosage and formulation
UY27725A1 (es) Material micronizado cristalino, procedimiento para su preparación y su utilización para la preparación de un medicamento.
CL2004000899A1 (es) Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion.
ES2158876T3 (es) Derivado de galantamina, un procedimiento para su preparacion y su utilizacion como medicamento.
UY28366A1 (es) Compuestos químicos
ES2187897T3 (es) Composicion anticancer.
ES2174054T3 (es) Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico.
AR019846A1 (es) Procedimiento para el tratamiento de semillas o bien de material de propagacion vegetal, procedimiento para la lucha contra las pestes animales y el empleode spinosynos en dichos procedimientos
AR012480A1 (es) Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona
PH12020550232A1 (en) Pesticide composition containing thidiazuron and polyglutamic acid
AR052345A1 (es) Composicion para cuidado oral del mal aliento
UY28622A1 (es) Agentes antibacterianos de quinolona
ES2177671T3 (es) Benzamida enterocinetica.
MX2021011491A (es) Polvos secos inhalables.
ES2052484T1 (es) N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.